Page last updated: 2024-11-07

metaraminol and Leukemia

metaraminol has been researched along with Leukemia in 1 studies

Metaraminol: A sympathomimetic agent that acts predominantly at alpha-1 adrenergic receptors. It has been used primarily as a vasoconstrictor in the treatment of HYPOTENSION.
metaraminol : A member of the class of phenylethanolamines that is 2-amino-1-phenylethanol substituted by a methyl group at position 2 and a phenolic hydroxy group at position 1. A sympathomimetic agent , it is used in the treatment of hypotension.

Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
FREIREICH, EJ1
LEVIN, RH1
WHANG, J1
CARBONE, PP1
BRONSON, W1
MORSE, EE1

Other Studies

1 other study available for metaraminol and Leukemia

ArticleYear
THE FUNCTION AND FATE OF TRANSFUSED LEUKOCYTES FROM DONORS WITH CHRONIC MYELOCYTIC LEUKEMIA IN LEUKOPENIC RECIPIENTS.
    Annals of the New York Academy of Sciences, 1964, Feb-28, Volume: 113

    Topics: Anti-Bacterial Agents; Blood Transfusion; Cell Division; Humans; Leukemia; Leukemia, Myelogenous, Ch

1964